Jan Slouka

4-Arylazo-3,5-diamino-1<i>H</i>-pyrazole CDK Inhibitors:  SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effects

Vladimı́r Kryštof, Petr Cankař, Iveta Fryšová et al. · Journal of Medicinal Chemistry · 2006 · 191 citations · Full text

Cyclocondensation reaction of heterocyclic carbonyl compounds, Part XIII: Synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines

Tomáš Gucký, Iveta Fryšová, Jan Slouka et al. · European Journal of Medicinal Chemistry · 2008 · 45 citations

Heterocyclic, Cyclocondensation Reaction, Organic Chemistry +6

Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines

Jakub Stýskala, Libuše Stýskalová, Jan Slouka et al. · European Journal of Medicinal Chemistry · 2007 · 28 citations

Medicinal Chemistry, Derivative (Chemistry), Derivatives +7

Synthesis of 1,2,4-triazino[5,6-b]- and imidazo[4,5-b]quinoline derivatives

Jan Slouka, Vojtěch Bekárek, Karel Nálepa et al. · Collection of Czechoslovak Chemical Communications · 1984 · 14 citations

Bioorganic Chemistry, Amino Derivative Iv, Biochemistry +9

Reactions of 2-(benzimidazol-2-yl)acetonitrile and its N-ethoxycarbonyl derivative with some azol-3-diazonium salts

Jan Slouka, Vojtěch Bekárek · Collection of Czechoslovak Chemical Communications · 1984 · 13 citations

Derivative (Chemistry), Derivatives, Azol-3-diazonium Salts +11